Table 1.

Patients' demographics and clinical characteristics of 8 kidney transplant recipients with COVID-19 infection

Patient	Age/sex	Tx date	Comorbidities	Fever	Respiratory involvements	Renal involvements	Baseline immunosuppression
1	21/F	Dec 2019	Hypertension	Yes	No	No	Pred-Tac-MMF
2	71/M	Feb 2016	Hypertension and post-Tx malignancy	No	Dry cough	No	Pred-Tac-MMF
3	50/M	Feb 2020	No	No	Productive cough	No	Pred-Tac-MMF
4	63/M	Dec 2005	Hypertension	Yes	No	AKI	Pred-Tac-MMF
5	47/F	Dec 2019	Bronchial asthma, aspergillosis	No	Dry cough + SOB	AKI	Pred-Tac-MMF
6	71/F	Nov 2015	DM type 2	Yes	No	No	Pred-Tac-MMF
7	40/F	Jun 2017	Hypertension	Yes	Dry cough	No	Pred-Tac-MMF
8	38/M	Jun 2013	No	Yes	Productive cough + SOB	No	Pred-Tac-Aza

COVID-19, coronavirus disease 2019; F, female; M, male; Tx date, date of transplant; post-Tx, post-transplant; DM, diabetes mellitus; SOB, shortness of breath; Pred, prednisolone; Tac, tacrolimus; MMF, mycophenolic acid; Aza, azathioprine.